Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 1—January 2004

Human Infection with M- Strain of Brucella canis

Jorge C. Wallach*†Comments to Author , Guillermo H. Giambartolomei†, Pablo C. Baldi†, and Carlos A. Fossati†‡
Author affiliations: *Hospital F. J. Muñiz, Buenos Aires, Argentina; †IDEHU, Universidad de Buenos Aires, Buenos Aires, Argentina; ‡Universidad Nacional de La Plata, La Plata, Argentina

Main Article


Cellular immune response in vitro to Brucella cytoplasmic proteinsa

Antigen Lymphocyte proliferation (SI) IL-2b (fold increase) IFN-γb (fold increase) IL-10b (fold increase)
Before therapy BLS 4 8 3 3
CP 3 10 7 4.5
End of therapy BLS 1 1 2 1
CP 2.5 6 4 2
55 days after end
of therapy BLS 1 1 1 1
CP 1 1 3 1

aBLS, Brucella lumazine synthase; CP, cytoplasmic proteins; SI, stimulation indices; IL, interleukin; IFN, interferon.
bBy reverse transcription-polymerase chain reaction.

Main Article

Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.